MedPath

Imaging vascularisation and morphometry in burns and scars by Optical Coherence Tomography

Completed
Conditions
1. Vascularisation en morphometry of burns and scars 2. Imaging of blood flow and tissue structure
10014982
Registration Number
NL-OMON40457
Lead Sponsor
Brandwondencentrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Age > 18 years
Competent or temporary incompetent (because of sedation and/or intubation)
Acute burn wound and a planned operation of the burn wound or:
Burn scar and an already planned excision (operation) of the scar

Exclusion Criteria

Language barrier
Pre-existing vascular problems both acquired (venous or arterial diseases) or congenital (such
as vascular malformations)
(Possible) pregnancy

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter is the utility of OCT to perform objective assessment<br /><br>of the vascularisation and surrounding tissue in burns and scars. Based on<br /><br>previous studies we expect to see a loss of layered structure in (deep) burn<br /><br>wounds and reduced to absent vascularisation. Moreover, a smaller birefringence<br /><br>and collagen denaturation can be found in thermally injured skin. To quantify<br /><br>the vascularisation in scars, we endeavour to identify the diameter of blood<br /><br>vessels and obtain vessel density . </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Scar: colour, elasticity, subjective scar outcome assessed by the POSAS.<br /><br>- Burn wound: depth assessment by the clinical impression of an experienced<br /><br>burn clinician.<br /><br><br /><br>The secondary study parameters are not used for determination of the utility of<br /><br>OCT but may be used to perform additional analyses.<br /><br>E.g.: assessing agreement between colour measurement and vessel density<br /><br>assessed by OCT.</p><br>
© Copyright 2025. All Rights Reserved by MedPath